Clinical Manifestations of Emerging Trichosporon spp. Infections, France

PubMed

Insights

Invasive Trichosporonaceae fungal infections are rare but deadly, showing resistance to echinocandins. Accurate species identification is crucial for managing these challenging fungal diseases.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Fungi in the Trichosporonaceae family are typically linked to colonization or allergic respiratory issues, not invasive illness.
  • Trichosporonaceae possess inherent resistance to echinocandin drugs, complicating treatment and leading to high mortality.
  • Invasive fungal infections pose a significant global health threat, particularly in immunocompromised individuals.

Purpose of the Study:

  • To conduct a nationwide analysis of invasive diseases caused by Trichosporon species and related fungi in France over two decades.
  • To investigate the clinical data, antifungal susceptibility profiles, and molecular identification of Trichosporon infections.
  • To highlight the importance of accurate species identification for epidemiological insights and patient management.

Main Methods:

  • A retrospective analysis of 112 cases of invasive Trichosporon infections diagnosed in France from 2000 to 2020.
  • Combination of clinical data review, antifungal susceptibility testing, and molecular identification techniques (e.g., sequencing).
  • Epidemiological and clinical data were correlated with identified species and genotypes.

Main Results:

  • Twelve Trichosporon species were identified, with Trichosporon asahii being the most prevalent, followed by the newly identified Trichosporon austroamericanum.
  • Clinical data revealed significant differences between species, including a higher incidence of T. asahii infections in children.
  • Substantial variations in antimicrobial drug susceptibility were observed among different Trichosporon species.

Conclusions:

  • Accurate identification of Trichosporon species is essential due to varying clinical presentations and microbiological characteristics.
  • Understanding species-specific traits, like antifungal resistance patterns, is critical for effective patient treatment and management.
  • This study underscores the need for continued surveillance and research into invasive Trichosporon infections.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
854
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
241
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
530
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
341
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
646
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
717